Another study followed people taking exenatide (another GLP-1 RA which is approved for treating diabetes) for six years and also discovered no major safety issues
Retatrutide triple receptor activation means the drug works by binding to three key hormone receptors in the body: GLP-1, GIP, and glucagon
Syringes: You will need two types: A larger syringe (often 3mL or 5mL) with a longer needle (e.g., 1 to 1.5 inches, 21-23 gauge) for drawing the BAC water and reconstituting the HCG
A 4-week phase 1b MAD trial at weekly doses of 1.0 mg, 2.25 mg, 3.5 mg, and 6.0 mg, reports mean weight loss of 0.1%, 0.5%, 2.4%, and 4.5%, respectively (112)
Chand at the Cleveland Clinic Weston said another side effect can be a reduction in bone density and an increased fracture risk
CrossRef Effect of an mHealth-assisted multifaceted lifestyle intervention on body-mass index, hepatic fat content and stiffness in children with overweight or obesity: a cluster randomised controlled trial Ping-Ping Zhang, Li Li, Hongqiao Fu, Enkar Nur, Duo Xu, Youxin Wang, Jiaying Gu, Miao Xu, Ye Zhou, Fangjing Shen, Xueying Li, Yunfei Xing, Shifeng Jin, Jialin Li, Qifa Song, Hui Li, Li Ming Wen, Hui Wang, Hai-Jun Wang eClinicalMedicine.2026